Court, Explained
U.S. Federal District Courts
←Back to docket
S.D.N.Y.Procedural orderFiled Oct. 27, 2025

Mitchell v. Taro Pharmaceutical Industries Ltd.

Full caption

Neal A. Mitchell, Individually and on Behalf of All Others Similarly Situated v. Taro Pharmaceutical Industries Ltd., Dilip Shanghvi, Abhay Gandhi, Uday Baldota, Linda Benshoshan, James Kedrowski, Oded Sarig, Robert Stein, Sudhir Valia and Sun Pharmaceutical Industries Ltd.

Judge
Cathy Seibel
Docket
7:24-cv-06818
Court
U.S. District Court · Southern District of New York
Pages
26
SecuritiesMotion to DismissCivil Procedure
In one sentence

In Neal A. Mitchell v. Taro Pharmaceutical, Judge Seibel granted defendants’ motion to dismiss securities-disclosure claims and closed the case.

Who this affects

Neal A. Mitchell and the proposed class of similarly situated shareholders; the named and individual defendants prevailed on the motion to dismiss, and the case was closed.

What happened

In Neal A. Mitchell v. Taro Pharmaceutical, Neal A. Mitchell challenged disclosures made to shareholders about Sun Pharmaceutical Industries Ltd.’s purchase of Taro’s minority-held shares. He claimed the proxy statement did not adequately describe BofA Securities’ role and calculations, the litigation contingency, and recommendations from Glass Lewis and Institutional Shareholder Services.

The court concluded that the proxy statement adequately disclosed BofA’s role and fairly summarized its financial analyses. It also concluded that the discussion of the litigation contingency and the Speakes settlement was not materially misleading, and that the proxy-adviser recommendations were not subject to the disclosure rule Mitchell invoked. Mitchell abandoned his separate Section 14(a) claims, and the court also rejected his control-person claims under Section 20(a).

Judge Seibel granted defendants’ motion to dismiss and closed the case. The court declined to grant Mitchell another opportunity to amend his complaint, but the opinion does not state that the dismissal was with or without prejudice.

The detailed version

For law students, journalists, and other readers who want the full reasoning

Case
Mitchell v. Taro Pharmaceutical Industries Ltd. · No. 7:24-cv-06818
Judge
Cathy Seibel
Date
Oct. 27, 2025

Background

Taro and Sun announced an agreement under which Sun would purchase Taro shares that Sun did not already own for $43 per share. Taro’s Special Committee, Audit Committee, and Board approved or recommended the transaction, and the shareholders later approved it. Taro’s proxy statement described negotiations, BofA Securities’ fairness opinion, BofA’s valuation analyses, a $141 million litigation-loss contingency related to antitrust matters, and recommendations from Glass Lewis and Institutional Shareholder Services.

Mitchell’s amended complaint asserted claims under Section 13(e) of the Securities Exchange Act and Section 14(a), alleging that the proxy statement omitted or misstated material information. He challenged the description of BofA’s role, the treatment of the litigation-loss contingency in BofA’s calculations, the discussion of the separate Speakes securities class action, and the disclosure of the Glass Lewis and Institutional Shareholder Services recommendations. He also asserted control-person claims under Section 20(a) against individual defendants. Mitchell later abandoned his Section 14(a) claims.

Legal standard

The defendants moved to dismiss under Rule 12(b)(6), which asks whether the complaint alleges enough facts to state a plausible legal claim. Because the claims involved alleged misleading statements or omissions in connection with securities transactions, the Private Securities Litigation Reform Act also required Mitchell to identify the challenged statements, explain why they were misleading, and plead supporting facts with particularity.

The court considered the amended complaint and the proxy statement because the complaint incorporated the proxy statement and relied heavily on it. The court did not decide whether Section 13(e) provides a private right to sue, noting that issue remains unsettled in the district. Instead, it assumed the issue without deciding it and resolved the claims on the ground that Mitchell had not alleged an actionable material misstatement or omission.

BofA’s role

Mitchell argued that the proxy statement failed to say whether BofA recommended the merger consideration. The court rejected that argument because the proxy statement expressly stated that the type and amount of consideration were determined through negotiations between the Special Committee and Sun, rather than by a financial adviser. The court also noted that the proxy statement described BofA’s role and stated that BofA gave an opinion about the fairness of the consideration, not about other aspects of the merger.

The court held that Mitchell’s suggestion that BofA might have recommended a target or floor price was hypothetical and unsupported by factual allegations. It therefore did not satisfy the heightened securities-pleading requirements.

BofA’s calculations and the litigation contingency

Mitchell argued that the proxy statement’s summary of BofA’s discounted-cash-flow and comparable-companies analyses was misleading because it stated that BofA added $1.295 billion in net cash, while BofA’s full presentation showed that the $141 million litigation contingency had been subtracted before calculating the per-share value. He also challenged a sensitivity analysis involving an additional $141 million.

The court acknowledged that the highlighted portion of the proxy statement, viewed alone, could be characterized as misleading. But it held that the proxy statement as a whole repeatedly disclosed that the $141 million contingency had been included in BofA’s valuation and that the sensitivity analysis reflected a doubling of that amount. The full financial presentation attached to the regulatory filing also showed how BofA accounted for the contingency.

The court concluded that shareholders were entitled to a fair summary of BofA’s analyses, not a disclosure detailed enough to let them independently recreate the valuation. Because the proxy statement and attached materials made clear that the contingency had been considered, Mitchell did not plausibly allege a material misstatement or omission. The court also said that any confusion about the stage of the calculation at which the $141 million was subtracted would not have been significant to a reasonable investor.

The Speakes litigation

Mitchell argued that the proxy statement misleadingly said that all settlement offers underlying the litigation contingency had been rejected because Taro had agreed in principle to settle the Speakes securities class action. The court rejected the argument for several reasons. It found that the contingency concerned ongoing, multi-jurisdiction antitrust litigation, while Speakes was a separate securities class action in the same court. The court also concluded that the proxy statement accurately described Sun’s position during negotiations, even if Mitchell disagreed with the valuation method.

The court further held that the Speakes settlement was publicly available before the shareholder vote. Information readily available in the public record, the court explained, generally cannot support a claim based on nondisclosure.

Glass Lewis and Institutional Shareholder Services

Mitchell argued that Taro violated Item 1015 of Regulation M-A by announcing that Glass Lewis and Institutional Shareholder Services recommended voting for the merger without providing their full reports or stating whether Taro paid for them.

The court distinguished those recommendations from a fairness opinion obtained by the company from a financial adviser. It found that Glass Lewis and Institutional Shareholder Services were independent proxy-advisory firms, were not selected or engaged by Taro, and did not participate in negotiating the transaction. Because Mitchell cited no authority requiring the requested disclosures for those independent recommendations, the court dismissed that claim.

Control-person claims

The court held that Mitchell’s Section 20(a) control-person claims also failed because such claims require an adequately pleaded underlying securities-law violation. Since Mitchell had not adequately alleged a primary violation, the control-person claims necessarily failed as well.

Leave to amend and disposition

Mitchell had already amended his complaint and had another opportunity to amend after defendants filed the motion to dismiss. He chose to rely on the amended complaint and did not request another amendment or identify additional facts that would cure the alleged defects. The court therefore declined to grant leave to amend.

The court granted defendants’ motion to dismiss, directed the Clerk to terminate the motion, and closed the case. The opinion does not state that the dismissal was with or without prejudice.

The authoritative version

Read the full 26-page opinion on CourtListener, the free public archive maintained by the Free Law Project.

Open opinion PDF →
Summary written with AI assistance. See how summaries are made. Spot something wrong? Tell us.